These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9759592)

  • 1. Nicotine carbomer enemas--pharmacokinetics of a revised formulation.
    Green JT; Rhodes J; Thomas GA; Evans BK; Feyerabend C; Russell MA; Sandborn WJ
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):260-5. PubMed ID: 9759592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of nicotine carbomer enemas: a new treatment modality for ulcerative colitis.
    Green JT; Thomas GA; Rhodes J; Evans BK; Russell MA; Feyerabend C; Fuller GS; Newcombe RG; Sandborn WJ
    Clin Pharmacol Ther; 1997 Mar; 61(3):340-8. PubMed ID: 9084459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An oral formulation of nicotine for release and absorption in the colon: its development and pharmacokinetics.
    Green JT; Evans BK; Rhodes J; Thomas GA; Ranshaw C; Feyerabend C; Russell MA
    Br J Clin Pharmacol; 1999 Oct; 48(4):485-93. PubMed ID: 10583017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine enemas for treatment of ulcerative colitis: a study of the pharmacokinetics and adverse events associated with three doses of nicotine.
    Ingram JR; Routledge P; Rhodes J; Marshall RW; Buss DC; Evans BK; Feyerabend C; Thomas GA
    Aliment Pharmacol Ther; 2004 Oct; 20(8):859-65. PubMed ID: 15479357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine tartrate liquid enemas for mildly to moderately active left-sided ulcerative colitis unresponsive to first-line therapy: a pilot study.
    Sandborn WJ; Tremaine WJ; Leighton JA; Lawson GM; Zins BJ; Compton RF; Mays DC; Lipsky JJ; Batts KP; Offord KP; Hurt RD; Green J
    Aliment Pharmacol Ther; 1997 Aug; 11(4):663-71. PubMed ID: 9305473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of nicotine tartrate after single-dose liquid enema, oral, and intravenous administration.
    Zins BJ; Sandborn WJ; Mays DC; Lawson GM; McKinney JA; Tremaine WJ; Mahoney DW; Zinsmeister AR; Hurt RD; Offord KP; Lipsky JJ
    J Clin Pharmacol; 1997 May; 37(5):426-36. PubMed ID: 9156375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotine enemas for active ulcerative colitis--a pilot study.
    Green JT; Thomas GA; Rhodes J; Williams GT; Evans BK; Russell MA; Feyerabend C; Rhodes P; Sandborn WJ
    Aliment Pharmacol Ther; 1997 Oct; 11(5):859-63. PubMed ID: 9354193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal nicotine compared with oral prednisolone therapy for active ulcerative colitis.
    Thomas GA; Rhodes J; Ragunath K; Mani V; Williams GT; Newcombe RG; Russell MA; Feyerabend C
    Eur J Gastroenterol Hepatol; 1996 Aug; 8(8):769-76. PubMed ID: 8864674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and in vitro/in vivo evaluations of bioadhesive buccal tablets for nicotine replacement therapy.
    Ikinci G; Senel S; Tokgözoğlu L; Wilson CG; Sumnu M
    Pharmazie; 2006 Mar; 61(3):203-7. PubMed ID: 16599260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal nicotine as maintenance therapy for ulcerative colitis.
    Thomas GA; Rhodes J; Mani V; Williams GT; Newcombe RG; Russell MA; Feyerabend C
    N Engl J Med; 1995 Apr; 332(15):988-92. PubMed ID: 7885427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermal nicotine for active ulcerative colitis.
    Pullan RD; Rhodes J; Ganesh S; Mani V; Morris JS; Williams GT; Newcombe RG; Russell MA; Feyerabend C; Thomas GA
    N Engl J Med; 1994 Mar; 330(12):811-5. PubMed ID: 8114833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a rectal nicotine delivery system for the treatment of ulcerative colitis.
    Dash AK; Gong Z; Miller DW; Huai-Yan H; Laforet J
    Int J Pharm; 1999 Nov; 190(1):21-34. PubMed ID: 10528093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dose-ranging pharmacokinetic study of nicotine tartrate following single-dose delayed-release oral and intravenous administration.
    Compton RF; Sandborn WJ; Lawson GM; Sheets AJ; Mays DC; Zins BJ; Tremaine WJ; Lipsky JJ; Mahoney DW; Zinsmeister AR; Offord KP; Hurt RD; Evans BK; Green J
    Aliment Pharmacol Ther; 1997 Oct; 11(5):865-74. PubMed ID: 9354194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic comparison of two nicotine transdermal systems, a 21-mg/24-hour patch and a 25-mg/16-hour patch: a randomized, open-label, single-dose, two-way crossover study in adult smokers.
    DeVeaugh-Geiss AM; Chen LH; Kotler ML; Ramsay LR; Durcan MJ
    Clin Ther; 2010 Jun; 32(6):1140-8. PubMed ID: 20637967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and retrograde colonic spread of budesonide enemas in patients with distal ulcerative colitis.
    Nyman-Pantelidis M; Nilsson A; Wagner ZG; Borgå O
    Aliment Pharmacol Ther; 1994 Dec; 8(6):617-22. PubMed ID: 7696451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Aminosalicylic acid enemas in patients with active ulcerative colitis. Influence of acidity on the kinetic pattern.
    Bondesen S; Nielsen OH; Jacobsen O; Rasmussen SN; Hansen SH; Halskov S; Binder V; Hvidberg EF
    Scand J Gastroenterol; 1984 Jul; 19(5):677-82. PubMed ID: 6382570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma fibrinogen in ulcerative colitis: the effect of disease activity and nicotine therapy in a randomised controlled trial.
    Ingram JR; Rhodes J; Collins PW; Williams GT; Newcombe RG; Thomas GA
    Dig Liver Dis; 2005 Nov; 37(11):832-7. PubMed ID: 16169302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of enema retention and preference in ulcerative colitis.
    Ingram JR; Rhodes J; Evans BK; Newcombe RG; Thomas GA
    Postgrad Med J; 2005 Sep; 81(959):594-8. PubMed ID: 16143691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability and therapeutic activity of alicaforsen (ISIS 2302) administered as a rectal retention enema to subjects with active ulcerative colitis.
    Miner PB; Geary RS; Matson J; Chuang E; Xia S; Baker BF; Wedel MK
    Aliment Pharmacol Ther; 2006 May; 23(10):1427-34. PubMed ID: 16669957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.